Tumor suppressor genes: At the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment

Lung Cancer

Volumn 34, Issue SUPPL. 2, 2001, Pages

  Hussain, S Perwez ^a   Hofseth, Lorne J ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AFB1; Cigarette smoking; HBV; Nitric oxide; p53 mutations

Indexed keywords

BENZO[A]PYRENE; PROTEIN P53; TOBACCO SMOKE;

CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONFERENCE PAPER; GENE MUTATION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

EID: 0035179779     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00339-7     Document Type: Conference Paper

References (119)

1. Chemical and physical carcinogenesis: Advances and perspectives for the 1990's
2. p53 mutations in human cancers
3. The p53 tumour suppressor gene
4. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
5. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression
6. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
7. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
8. Response: Re: Relationship between p53 mutations and inducible nitric oxide synthase in human colorectal cancer
9. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase (NOS2) expression by wild-type p53
10. Upregulation of NOS2 expression in cancer-prone p53 knockout mice
11. p53 and vascular endothelial growth factor regulate tumour growth of NOS2-expressing human carcinoma cells
12. p53 mutations in lung cancers from non-smoking atomic-bomb survivors
13. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
14. Gender comparisons in human lung cancer: Analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression
15. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts
16. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
17. p53 modulation of TFIIH-associated nucleotide excision repair activity
18. The XPB and XPD helicases are components of the p53-mediated apoptosis pathway
19. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
20. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
21. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
22. Genetic basis for p53 overexpression in human breast cancer
23. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus
24. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas
25. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung
26. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
27. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
28. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
29. Aberrations of p53 gene in human hepatocellular carcinoma from China
30. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico
31. Aflatoxin B1 induces the transversion of G-- > T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
32. Aflatoxin B1 induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
33. Geographic variation of p53 mutational profile in nonmalignant human liver
34. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis
35. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent
36. Genetic heterogeneity of hepatocellular carcinoma
37. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
38. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
39. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells
40. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
41. Transcriptional trans-activating function of hepatitis B virus
42. Trans-activation of viral enhancers by the hepatitis B virus X protein
43. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA
44. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
45. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
46. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
47. Functional inactivation but not structural mutation of p53 causes liver cancer
48. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
49. Hepatitis B virus x mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis
50. Hepatitis B virus X protein inhibits nucleotide excision repair
51. Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse
52. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA
53. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
54. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung
55. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells
56. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
57. Sunburn and p53 in the onset of skin cancer
58. p53
59. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers
60. Clinical implications of the p53 tumor-suppressor gene
61. Nitric oxide: Physiology, pathophysiology, and pharmacology
62. Nitric oxide synthases: Roles, tolls, and controls
63. Nitric oxide: A physiologic messenger molecule
64. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
65. The role of nitric oxide (NO) in the carcinogenic process
66. Nitric oxide synthase structure and mechanism
67. Nitric oxide synthase: Expression and expressional control of the three isoforms
68. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo
69. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa
70. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
71. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors
72. Nitric oxide synthase activity in human gynecological cancer
73. Nitric oxide synthase activity in human breast cancer
74. Expression of nitric oxide synthase in human central nervous system tumors
75. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
76. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants
77. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis
78. Chronic hepatitis C virus infection in humans: Induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis
79. Roles of nitric oxide in tumor growth
80. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor
81. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine
82. Mechanisms for nitric oxide-induced cell death: Involvement of apoptosis
83. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
84. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
85. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
86. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer
87. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours
88. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
89. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
90. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
91. Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
92. Base analog and neighboring base effects on substrate specificity of recombinant human G:T mismatch-specific thymine DNA-glycosylase
93. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
94. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
95. New paradigms for cancer prevention
96. Combinations for cancer prevention
97. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
98. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells
99. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
100. p53 expression in nitric oxide-induced apoptosis
101. Identification of a p53-dependent negative response element in the bcl-2 gene
102. Regulation of the human hsp70 promoter by p53
103. Molecular epidemiology and the genetics of environmental cancer
104. Carcinogenesis
105. Environment and cancer: Who are susceptible?
106. Genetic testing for cancer risk
107. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: Oxyradical overload diseases
108. Sequential molecular genetic changes in lung cancer development
109. Clonal evolution of lung tumors
110. Clonal genetic alterations in the lungs of current and former smokers
111. Analysis of oncogenes and suppressor genes in lung cancer and bronchial lesions from high risk group
112. Molecular damage in the bronchial epithelium of current and former smokers
113. I.A.R.C. Benzo[a]pyrene
114. Polynuclear aromatic carcinogens
115. Carcinogenic polynuclear hydrocarbons bind to macromolecules in cultured human bronchi
116. Structures of benzo(a)pyrene-nucleic acid adducts formed in human and bovine bronchial explants
117. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes
118. Invasive tumors derived from xenotransplanted, immortalized human cells after in vivo exposure to chemical carcinogens